# ::id 1
# ::snt An experimental cancer drug that works after a
(x4 / drug
	:mod (x2 / experiment-01)
	:mod (x3 / cancer)
	:ARG0-of (x6 / work
		:time (x7 / after)))

# ::id 2
# ::snt single round of treatment appears to be the most effective medicine
(x5 / appear-02
	:ARG1 (x2 / round
		:mod (x1 / single)
		:consist-of (x4 / treat-03))
	:ARG1 (x11 / medicine
		:mod (x10 / effective
			:degree (x9 / most))))

# ::id 3
# ::snt yet for a rare form of leukemia, according to a study.
(x1 / yet
	:part-of (x12 / study-01
		:ARG1 (x5 / form
			:mod (x4 / rare)
			:mod (x7 / disease
				:name (n / name
					:op1 "leukemia")))))

# ::id 4
# ::snt The drug _ called 2-chlorodeoxyadenosine, or 2-CdA _ has
(x7 / or
	:op1 (x3 / _
		:domain (x2 / drug)
		:ARG1-of (x4 / call-01
			:ARG2 (x5 / 2-chlorodeoxyadenosine)))
	:op2 (x10 / have-03))

# ::id 5
# ::snt produced complete remissions in almost all hairy cell leukemia
(x1 / produce-01
	:ARG1 (x3 / remission
		:mod (x2 / complete))
	:location (x9 / disease
		:name (n / name
			:op1 "leukemia")
		:quant (x6 / all
			:degree (x5 / almost))
		:mod (x7 / hairy)
		:mod (x8 / cell)))

# ::id 6
# ::snt patients treated, and none has relapsed so far.
(x4 / and
	:op1 (x2 / treat-01
		:ARG0 (x1 / patient))
	:op2 (x7 / relapse-01
		:ARG0 x1
		:ARG0 (x5 / none)))

# ::id 7
# ::snt Researchers who developed and tested the medicine report that it
(x8 / report-01
	:ARG0 (x1 / person
		:ARG0-of (r / research-01)
		:ARG1-of (x3 / develop-02
			:ARG1 (x7 / medicine
				:ARG1-of (x5 / test-01))))
	:time (x9 / that))

# ::id 8
# ::snt "may well be the drug of choice in the treatment of hairy cell
(x2 / possible
	:domain (x6 / drug
		:ARG1-of (x11 / treat-03
			:ARG1 (x14 / cell
				:mod (x13 / hairy)))))

# ::id 9
# ::snt leukemia."
(x1 / disease
	:name (n / name
		:op1 "leukemia"))

# ::id 10
# ::snt The drug also has been used successfully against chronic
(x6 / use-01
	:ARG1 (x2 / drug)
	:mod (x3 / also)
	:ARG1-of (x7 / succeed-01)
	:ARG2 (x9 / chronic))

# ::id 11
# ::snt lymphocytic leukemia. It, like hairy cell leukemia, is a cancer of
(x2 / disease
	:name (n / name
		:op1 "leukemia")
	:mod (x1 / lymphocytic)
	:ARG1 (x13 / cancer
		:prep-within (x9 / disease
			:name (n1 / name
				:op1 "leukemia")
			:mod (x7 / hairy)
			:mod (x8 / cell))))

# ::id 12
# ::snt the white blood cells, which produce disease-fighting antibodies.
(x4 / cell
	:null_edge (x2 / white)
	:mod (x3 / blood)
	:ARG0-of (x7 / produce-01
		:ARG1 (x9 / antibody
			:mod (x8 / disease-fighting))))

# ::id 13
# ::snt The latest study, published in Thursday's New England Journal of
(x3 / study-01
	:time (x2 / late
		:degree (m / most))
	:ARG1-of (x5 / publish-01
		:medium (x11 / journal
			:null_edge (x9 / null_tag)
			:poss (x10 / country
				:name (n / name
					:op1 "England"))
			:time (xap0 / date-entity
				:weekday (x7 / thursday)))))

# ::id 14
# ::snt Medicine, was directed by Dr. Lawrence D. Piro of the Scripps
(x4 / direct-01
	:ARG1 (x1 / medicine)
	:ARG2 (x7 / name
		:op1 "Lawrence"
		:op2 "D."
		:op3 "Piro"
		:ARG0-of (x12 / scripps)))

# ::id 15
# ::snt Clinic and Research Foundation in La Jolla, Calif. Scripps recently
(x1 / government-organization
	:name (n / name
		:op1 "Clinic"
		:op2 "and"
		:op3 "Research"
		:op4 "Foundation"
		:op5 "in"
		:op6 "La"
		:op7 "Jolla"
		:op8 ","
		:op9 "Calif."
		:op10 "."
		:op11 "Scripps")
	:location (x7 / country
		:name (n1 / name
			:op1 "Jolla")
		:null_edge (x6 / country
			:name (n2 / name
				:op1 "La"))
		:null_edge (x9 / country
			:name (n3 / name
				:op1 "Calif.")))
	:time (x12 / recent))

# ::id 16
# ::snt made an agreement with Johnson & Johnson's Ortho Pharmaceuticals to
(x3 / agree-01
	:ARG1 (x5 / government-organization
		:name (n / name
			:op1 "Johnson"
			:op2 "&"
			:op3 "Johnson"
			:op4 "'s"
			:op5 "Ortho"
			:op6 "Pharmaceuticals")))

# ::id 17
# ::snt produce and distribute the drug once it's approved by the U.S. Food
(x2 / and
	:op1 (x1 / produce-01
		:ARG1 (x5 / drug)
		:condition (x9 / approve-01
			:ARG0 (x13 / food)))
	:op3 (x3 / distribute-01))

# ::id 18
# ::snt and Drug Administration.
(x1 / and
	:op1 (x3 / government-organization
		:name (n / name
			:op1 "Administration")
		:null_edge (x2 / null_tag)))

# ::id 19
# ::snt In the published work, doctors gave the drug to 12 patients as
(x4 / work-01
	:ARG1-of (x3 / publish-01)
	:ARG0 (x6 / doctor)
	:ARG1 (x9 / drug)
	:ARG2 (x12 / patient
		:quant 12))

# ::id 20
# ::snt far back as four years ago. In 11, the disease disappeared and they
(x2 / back-01
	:degree (x1 / far)
	:null_edge (x14 / and
		:op1 (x13 / disappear-01
			:duration 11
			:ARG1 (x12 / disease)
			:time (xap0 / before
				:quant (x5 / temporal-quantity
					:unit (y / year)
					:null_edge (x4 / null_tag))))))

# ::id 21
# ::snt remain disease free.
(x1 / remain-01
	:ARG3 (x3 / free-01
		:ARG2 (x2 / disease)))

# ::id 22
# ::snt In all, the Scripps doctors have treated 24 patients with almost
(x8 / treat-01
	:ARG0 (x6 / doctor
		:mod (x5 / organization
			:name (n / name
				:op1 "Scripps")))
	:ARG1 (x10 / patient
		:quant 24)
	:ARG2 (x12 / almost))

# ::id 23
# ::snt complete success. However, they caution that longer follow up will
(x7 / caution-01
	:ARG1 (x2 / succeed-01
		:mod (x1 / complete))
	:ARG0 (x6 / they)
	:ARG1 (x12 / will
		:null_edge (x10 / follow-02)))

# ::id 24
# ::snt be necessary before they can be sure they have actually cured the
(x2 / necessary
	:time (x3 / before
		:op1 (x5 / possible
			:domain (x7 / sure)
			:domain (xap0 / and
				:op2 (x11 / cure-01
					:mod (x10 / actual))))))

# ::id 25
# ::snt disease.
(x1 / disease)

# ::id 26
# ::snt Two other treatments for hairy cell leukemia have been developed
(x10 / develop-02
	:ARG1 (x3 / treat-03
		:quant 2
		:mod (x2 / other)
		:purpose (x7 / disease
			:name (n / name
				:op1 "leukemia")
			:mod (x5 / hairy)
			:mod (x6 / cell))))

# ::id 27
# ::snt in recent years. They are interferon and deoxycoformycin, a drug
(x8 / and
	:op1 (x7 / interferon
		:duration (x3 / temporal-quantity
			:unit (y / year)
			:mod (x2 / recent))
		:domain (x5 / they))
	:op2 (x9 / deoxycoformycin))

# ::id 28
# ::snt that is similar to 2-CdA. However, interferon is less effective,
(x3 / resemble-01
	:op (s / similar)
	:ARG1 (x1 / that)
	:ARG2 (x5 / 2-cda)
	:null_edge (x12 / effective
		:domain (x9 / interferon)
		:degree (x11 / less)))

# ::id 29
# ::snt and both of those treatments produce serious side effects.
(x1 / and
	:op1 (x6 / produce-01
		:ARG1 (x5 / treat-03)
		:ARG1 (x9 / effect-01
			:mod (x7 / serious)
			:mod (x8 / side))))

# ::id 30
# ::snt By contrast, the only unwanted effect of 2-CdA was a few days of
(x7 / effect-01
	:beneficiary (x2 / contrast-01)
	:mod (x5 / only)
	:mod (x6 / unwanted)
	:ARG1 (x9 / 2-cda)
	:ARG1 (x12 / few
		:op1 (x13 / temporal-quantity
			:unit (d / day)
			:ARG1-of (x14 / include-91))))

# ::id 31
# ::snt 
(x4 / experience-01
	:ARG0 (x3 / patients
		:null_edge (x1 / fever))
	:ARG1 (x12 / or
		:op1 (x6 / nausea
			:polarity -
			:mod (x13 / other))
		:op2 (x9 / loss
			:ARG1 (x8 / hair))
		:op2 (x11 / rash)))

# ::id 32
# ::snt symptoms typical of cancer therapy. Also unlike other treatments,
(x1 / symptom
	:mod (x2 / typify-01
		:domain (x5 / therapy
			:mod (x4 / cancer)
			:ARG3-of (x10 / treat-03
				:mod (x9 / other)))))

# ::id 33
# ::snt this one appears to work after a single seven-day course of therapy.
(x3 / appear-02
	:ARG1 (x2 / one
		:mod (x1 / this))
	:ARG1 (x5 / work-01
		:ARG0 x2
		:time (x6 / after
			:op1 (x10 / course-01
				:ARG1 (x12 / therapy)))))

